NCT05645588

Brief Summary

This study aims to investigate the effect of pranayama (yoga-breathing techniques) on post-traumatic symptom severity in patients with post-traumatic stress disorder undergoing standard, out-patient, trauma-focused psychotherapy. Therefore, short pranayama sessions of 5-10 minutes will be provided to the patients directly at the begin of each of psychotherapy unit, while the control group will receive standard, trauma-focused psychotherapy alone.

Trial Health

45
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
22mo left

Started Jan 2025

Typical duration for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Jan 2025Feb 2028

First Submitted

Initial submission to the registry

December 1, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 9, 2022

Completed
2.1 years until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2028

Last Updated

March 30, 2025

Status Verified

March 1, 2025

Enrollment Period

2.1 years

First QC Date

December 1, 2022

Last Update Submit

March 25, 2025

Conditions

Keywords

Posttraumatic Stress DisorderPranayamaYogaComplimentary TherapiesSomatic Symptom DisorderSSDPTSDSafetyEffectivenessRandomized Controlled Trail

Outcome Measures

Primary Outcomes (1)

  • Intensity of posttraumtic symptoms

    Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): The PCL-5 is a standard 20-item scale with a sum score ranging from 0 to 80 points. The cut-off point for clinically relevant symptom severity is 33 points.

    week 10

Secondary Outcomes (7)

  • Health-related quality of life

    week 10

  • Anxiety

    week 10

  • Depression

    week 10

  • Breath Holding Duration

    week 10

  • Adverse Events

    weeks 1,2,3,4,5,6,7,8,9,10

  • +2 more secondary outcomes

Other Outcomes (5)

  • Treatment Expectation

    week 0

  • Interoceptive Awareness

    weeks 0+10

  • Social Readjustment after life events

    weeks 0+10

  • +2 more other outcomes

Study Arms (2)

Pranayama assisted trauma-focused standard psychotherapy (TF-SPT).

EXPERIMENTAL

Behavioral: Pranayama assisted trauma-focused standard psychotherapy (TF-SPT) The pranayama intervention is placed directly at the begin of the respective TF-SPT unit and will be repeated for 10 subsequent TF-SPT units.

Behavioral: Pranayama assisted trauma-focused standard psychotherapy (TF-SPT)

Trauma-focused standard psychotherapy (TF-SPT)

ACTIVE COMPARATOR

Behavioral: Patients wait for 10 TF-SPT units and then are offered to learn pranayama.

Behavioral: Trauma-focused standard psychotherapy (TF-SPT)

Interventions

To prepare patients for the TF-SPT, they received 5-10 minutes of pranayama at the begin of each of the 10 TF-SPT units.

Pranayama assisted trauma-focused standard psychotherapy (TF-SPT).

Patients wait for 10 TF-SPT units and then are offered to learn pranayama

Trauma-focused standard psychotherapy (TF-SPT)

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed PTSD according to ICD-10 F43.1
  • PCL-5 Score of at least 33 points
  • Undergoing outpatient standard trauma-focused psychotherapy (Cognitive Behavioral Therapy, Psychodynamic Psychotherapy, or Systemic Psychotherapy)

You may not qualify if:

  • Pre-existing mental or somatic conditions that are unlikely to result in correct or safe performance of pranayama:
  • Substance dependence current use (ICD-10 F10.X, F11.X).
  • Dementia (ICD-10 F00-F03)
  • Somatoform Disorder (ICD F45.X) of moderate or severe degree according to DSM-5 300.82: ≥ 2 reactions (cognitive, emotional, or behavioral) to somatic symptoms (≥ 2 criterion-B)
  • Severe cardiovascular disease: presence of cardiac or vascular implants or grafts, e.g., pacemaker (ICD-10 Z95.X), condition after organ or tissue transplantation (ICD-10 Z94.X)
  • Acute adverse events occurring during pranayama at baseline (including neck pain, subjective sensation of pressure in the lungs, anxiety / panic)
  • Cancer diagnosis in the past 5 years (ICD-10 C00-C97, D37-48)
  • Pregnancy / breastfeeding
  • Regular pranayama practice in the last 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants and Therapists (Care Provider) could not be blinded according to the nature of the intervention. However, therapists will be blinded to allocation concealment as they do not be aware of the patients' group assignment at baseline assessment until they open the opaque randomization envelope, which contains the patient randomization number and group assignment. The random sequence generation and the envelopes were prepared by the study coordinator who is not involved patient recruitment. Patients received post intervention questionnaires from a study assistant/nurse of the respective outpatient department (outcome assessor) who is also blinded to the patients' group assignment. After completing the questionnaires, the study assistant will sent them to study coordinator so that the therapist could not influence the patients' answers.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Research

Study Record Dates

First Submitted

December 1, 2022

First Posted

December 9, 2022

Study Start

January 1, 2025

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 1, 2028

Last Updated

March 30, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE